| Authors: |
Kleine Schaars K; Outpatient Clinic Pharmacogenetics, Parnassia Psychiatric Institute, Amsterdam, the Netherlands.; Centre for Human Drug Research, Leiden, the Netherlands.; Leiden University Medical Center, Leiden, the Netherlands., Young AH; Division of Psychiatry, Imperial College London, United Kingdom.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Moldovan R; Division of Evolution and Genomic Sciences, School of Biological Science, University of Manchester, United Kingdom.; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.; Department of Psychology, Babeş-Bolyai University, Romania., Van der Eycken E; Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe), Brussels, Belgium., Schuster F; Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe), Brussels, Belgium., Klopper J; Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe), Brussels, Belgium., Heilbronner U; Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Germany., Kas MJH; Groningen Institute for Evolutionary Life Sciences, University of Groningen, the Netherlands., van Westrhenen R; Outpatient Clinic Pharmacogenetics, Parnassia Psychiatric Institute, Amsterdam, the Netherlands.; Centre for Human Drug Research, Leiden, the Netherlands.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; St. John's National Academy of Health Sciences, Bangalore, India. |
